Sarepta Therapeutics Inc. (SRPT)
58.19
-4.28 (-6.85%)
At close: Apr 03, 2025, 1:07 PM
Sarepta Therapeutics Analyst Ratings
Total Analysts
21
Consensus Rating
Buy
Price Target
179
Upside
207.61
Ratings History
| Analyst | Firm | Rating | Action | Price Target | Upside | Date |
| Needham | Buy | Maintains | 202 183 | 214.49% | Apr 3, 2025 | |
| HC Wainwright & Co. | Hold | Upgrades | 75 75 | 28.89% | Apr 2, 2025 | |
| RBC Capital | Hold | Downgrades | 161 87 | 49.51% | Mar 31, 2025 |
Trade Smarter, Not Harder
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.